• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

土耳其一家三级护理医院在疫苗接种时代之前医护人员中SARS-CoV-2抗体的血清流行率及相关因素

Seroprevalence of SARS-CoV-2 Antibodies and Associated Factors in Healthcare Workers before the Era of Vaccination at a Tertiary Care Hospital in Turkey.

作者信息

Sonmezer Meliha Cagla, Erul Enes, Sahin Taha Koray, Rudvan Al Ipek, Cosgun Yasemin, Korukluoglu Gulay, Zengin Humeyra, Telli Dizman Gülçin, Inkaya Ahmet Cagkan, Unal Serhat

机构信息

Infectious Diseases and Clinical Microbiology Department, Hacettepe University Faculty of Medicine, 06100 Ankara, Turkey.

Internal Medicine Department, Hacettepe University Faculty of Medicine, 06100 Ankara, Turkey.

出版信息

Vaccines (Basel). 2022 Feb 8;10(2):258. doi: 10.3390/vaccines10020258.

DOI:10.3390/vaccines10020258
PMID:35214715
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8875971/
Abstract

Healthcare workers (HCWs), as frontliners, are assumed to be among the highest risk groups for COVID-19 infection, especially HCWs directly involved in patient care. However, the data on the COVID-19 infection and seroprevalence rates are limited in HCWs. Therefore, we aimed to evaluate the seroprevalence rates in HCWs according to risk groups for COVID-19 contraction in a large cross-sectional study from a tertiary care hospital in Turkey. We enrolled 1974 HCWs before the vaccination programs. In two separate semi-quantitative ELISAs, either IgA or IgG antibodies against SARS-CoV-2 spike protein subunit 1 (S1) were measured. The proportion of positive test results for IgG, IgA, or both against SARS-CoV-2 of study subjects was 19% (375/1974). Frontline HCWs who had contact with patients (21.7%, RR 2.1 [1.51-2.92]) and HCWs in working in the COVID-19 units, intensive care units, or emergency department (19.7%, RR 1.61 [1.12-2.32]) had a notably higher Anti-SARS-CoV-2 IgG compared to the rest of HCWs who has no daily patient contacts ([11.1%]; < 0.0001). HCWs who care for regular patients in the medium-risk group have also experienced a sustained higher risk of exposure to SARS-CoV-2. We should enhance the precaution against COVID-19 to protect HCW's safety through challenging times.

摘要

医护人员作为一线工作者,被认为是感染新冠病毒风险最高的群体之一,尤其是直接参与患者护理的医护人员。然而,关于医护人员新冠病毒感染情况和血清阳性率的数据有限。因此,我们旨在通过土耳其一家三级护理医院的一项大型横断面研究,评估根据感染新冠病毒风险组别的医护人员血清阳性率。在疫苗接种计划之前,我们招募了1974名医护人员。在两项独立的半定量酶联免疫吸附测定中,检测了针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白亚基1(S1)的IgA或IgG抗体。研究对象中针对SARS-CoV-2的IgG、IgA或两者的阳性检测结果比例为19%(375/1974)。与患者有接触的一线医护人员(21.7%,相对风险2.1[1.51 - 2.92])以及在新冠病房、重症监护病房或急诊科工作的医护人员(19.7%,相对风险1.61[1.12 - 2.32]),与没有日常患者接触的其他医护人员相比([11.1%]),其抗SARS-CoV-2 IgG水平显著更高(<0.0001)。在中等风险组中护理普通患者的医护人员也持续面临着更高的接触SARS-CoV- 的风险。在艰难时期,我们应加强针对新冠病毒的预防措施,以保护医护人员的安全。

相似文献

1
Seroprevalence of SARS-CoV-2 Antibodies and Associated Factors in Healthcare Workers before the Era of Vaccination at a Tertiary Care Hospital in Turkey.土耳其一家三级护理医院在疫苗接种时代之前医护人员中SARS-CoV-2抗体的血清流行率及相关因素
Vaccines (Basel). 2022 Feb 8;10(2):258. doi: 10.3390/vaccines10020258.
2
Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study.在 COVID-19 大流行的第一波和第二波期间,一家三级癌症中心的癌症患者和医护人员中 SARS-CoV-2 抗体的血清阳性率的平行进化和差异:canSEROcov-II 横断面研究。
Eur J Cancer. 2022 Apr;165:13-24. doi: 10.1016/j.ejca.2022.01.005. Epub 2022 Feb 1.
3
Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust.在一家大型英国国家医疗服务体系(NHS)基金会信托机构中,英国医护人员在疫情第一波期间SARS-CoV-2血清阳性率的风险因素。
medRxiv. 2021 Jul 8:2021.07.07.21260151. doi: 10.1101/2021.07.07.21260151.
4
SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.瑞士一家三级保健中心第一波疫情结束时医护人员中 SARS-CoV-2 血清流行率:一项横断面研究。
BMJ Open. 2021 Jul 5;11(7):e049232. doi: 10.1136/bmjopen-2021-049232.
5
Seroprevalence of Covid-19 infection among healthcare workers: A study from a tertiary care hospital in the National Capital Region of India.印度国家首都地区一家三级护理医院医护人员中新冠病毒感染的血清流行率:一项研究
Natl Med J India. 2022 Jul-Aug;35(4):219-220. doi: 10.25259/NMJI_345_21.
6
The Longitudinal Analysis on the Anti-SARS-CoV-2 Antibodies among Healthcare Workers in Poland-Before and after BNT126b2 mRNA COVID-19 Vaccination.波兰医护人员接种BNT126b2 mRNA新冠疫苗前后抗SARS-CoV-2抗体的纵向分析
Vaccines (Basel). 2022 Sep 20;10(10):1576. doi: 10.3390/vaccines10101576.
7
Higher rate of SARS-CoV-2 IgG seropositivity in hospital-based healthcare workers compared to elderly care staff in a Swedish low-prevalence region: a cross-sectional study.在瑞典低流行地区,与老年护理人员相比,医院医护人员的 SARS-CoV-2 IgG 血清阳性率更高:一项横断面研究。
Infect Dis (Lond). 2021 Nov-Dec;53(12):920-929. doi: 10.1080/23744235.2021.1959949. Epub 2021 Aug 5.
8
Seroprevalence study of SARS-CoV-2 antibodies in healthcare workers following the first wave of the COVID-19 pandemic in a tertiary-level hospital in the south of Ireland.爱尔兰南部一家三级医院在 COVID-19 大流行第一波后医护人员中 SARS-CoV-2 抗体的血清阳性率研究。
BMJ Open. 2021 Jun 8;11(6):e051415. doi: 10.1136/bmjopen-2021-051415.
9
Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India.印度医护人员中 SARS-CoV-2 抗体的血清阳性率及其对感染控制实践的影响。
Indian J Med Res. 2021;153(1 & 2):207-213. doi: 10.4103/ijmr.IJMR_3911_20.
10
Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile.智利一家三级医院在新冠疫情第一波期间对一线医护人员的 SARS-CoV-2 IgG 血清阳转进行的纵向评估。
BMC Infect Dis. 2021 May 26;21(1):478. doi: 10.1186/s12879-021-06208-2.

引用本文的文献

1
Risk of COVID-19 infection among frontline healthcare workers during the COVID-19 pandemic.新型冠状病毒肺炎大流行期间一线医护人员感染新型冠状病毒肺炎的风险
World J Virol. 2025 Jun 25;14(2):99663. doi: 10.5501/wjv.v14.i2.99663.
2
Antibody Responses to SARS-CoV-2 among Health Care Workers in North-Eastern Tanzania.坦桑尼亚东北部医护人员对新冠病毒的抗体反应
East Afr Health Res J. 2024;8(3):305-314. doi: 10.24248/eahrj.v8i3.799. Epub 2025 Jan 30.
3
COVID-19 Antibody Levels among Various Vaccination Groups, One-Year Antibody Follow-Up in Two University Hospitals from Western and Central Turkey.土耳其西部和中部两家大学医院不同疫苗接种组的COVID-19抗体水平,为期一年的抗体随访
Vaccines (Basel). 2024 Jan 7;12(1):59. doi: 10.3390/vaccines12010059.
4
Seroprevalence and factors associated with SARS-CoV-2 infection among healthcare workers: cross-sectional study.医护人员中 SARS-CoV-2 感染的血清流行率及相关因素:横断面研究。
BMC Infect Dis. 2023 Nov 6;23(1):761. doi: 10.1186/s12879-023-08760-5.
5
Antibodies to NCP, RBD and S2 SARS-CoV-2 in Vaccinated and Unvaccinated Healthcare Workers.接种疫苗和未接种疫苗的医护人员体内针对新型冠状病毒肺炎(NCP)、受体结合域(RBD)和刺突蛋白2(S2)的抗体
Vaccines (Basel). 2022 Jul 22;10(8):1169. doi: 10.3390/vaccines10081169.
6
Detection of SARS-CoV-2 RNA by Reverse Transcription-Polymerase Chain Reaction (RT-PCR) on Self-Collected Nasal Swab Compared With Professionally Collected Nasopharyngeal Swab.与专业采集的鼻咽拭子相比,通过逆转录聚合酶链反应(RT-PCR)检测自我采集的鼻拭子中的SARS-CoV-2 RNA。
Cureus. 2022 Jun 3;14(6):e25618. doi: 10.7759/cureus.25618. eCollection 2022 Jun.
7
Non-Pharmacological Preventive Measures Had an Impact on COVID-19 in Healthcare Workers before the Vaccination Effect: A Cohort Study.非药物性预防措施在疫苗接种效果之前对医护人员的 COVID-19 产生了影响:一项队列研究。
Int J Environ Res Public Health. 2022 Mar 18;19(6):3628. doi: 10.3390/ijerph19063628.

本文引用的文献

1
Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis.公共卫生措施在降低新冠病毒发病率、SARS-CoV-2 传播率和新冠死亡率方面的有效性:系统评价和荟萃分析。
BMJ. 2021 Nov 17;375:e068302. doi: 10.1136/bmj-2021-068302.
2
Differences in risk for SARS-CoV-2 infection among healthcare workers.医护人员感染新冠病毒的风险差异。
Prev Med Rep. 2021 Dec;24:101518. doi: 10.1016/j.pmedr.2021.101518. Epub 2021 Aug 21.
3
Risk Groups for SARS-CoV-2 Infection among Healthcare Workers: Community Versus Hospital Transmission.医护人员中感染新型冠状病毒2的风险群体:社区传播与医院传播
Infect Dis Rep. 2021 Aug 13;13(3):724-729. doi: 10.3390/idr13030067.
4
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey.一种灭活全病毒 SARS-CoV-2 疫苗(克尔来福)的有效性和安全性:在土耳其进行的一项双盲、随机、安慰剂对照、3 期临床试验的中期结果。
Lancet. 2021 Jul 17;398(10296):213-222. doi: 10.1016/S0140-6736(21)01429-X. Epub 2021 Jul 8.
5
Anti-SARS-CoV-2 Antibody Levels Measured by the AdviseDx SARS-CoV-2 Assay Are Concordant with Previously Available Serologic Assays but Are Not Fully Predictive of Sterilizing Immunity.AdviseDx SARS-CoV-2 抗体检测试剂盒检测的抗 SARS-CoV-2 抗体水平与先前可用的血清学检测方法一致,但不能完全预测是否具有中和抗体。
J Clin Microbiol. 2021 Aug 18;59(9):e0098921. doi: 10.1128/JCM.00989-21.
6
The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis.疫苗时代前医护人员中 SARS-CoV-2 抗体的血清流行率:系统评价和荟萃分析。
Clin Microbiol Infect. 2021 Sep;27(9):1242-1249. doi: 10.1016/j.cmi.2021.05.036. Epub 2021 Jun 8.
7
[SARS-CoV-2 Seroprevalence Among Healthcare Workers: Retrospective Analysis of the Data From A University Hospital in Turkey].[土耳其一家大学医院医护人员中新冠病毒血清流行率:回顾性数据分析]
Mikrobiyol Bul. 2021 Apr;55(2):223-232. doi: 10.5578/mb.20219908.
8
Risk Factors Associated With SARS-CoV-2 Seropositivity Among US Health Care Personnel.美国医护人员中与 SARS-CoV-2 血清阳性相关的危险因素。
JAMA Netw Open. 2021 Mar 1;4(3):e211283. doi: 10.1001/jamanetworkopen.2021.1283.
9
Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan.日本东京一家大型国立医院及其附属机构中抗新冠病毒 2 型抗体的血清流行率。
J Infect. 2021 Apr;82(4):e1-e3. doi: 10.1016/j.jinf.2021.01.010. Epub 2021 Jan 29.
10
SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis.SARS-CoV-2、SARS-CoV 和 MERS-CoV 的病毒载量动态、病毒脱落持续时间和传染性:系统评价和荟萃分析。
Lancet Microbe. 2021 Jan;2(1):e13-e22. doi: 10.1016/S2666-5247(20)30172-5. Epub 2020 Nov 19.